507 related articles for article (PubMed ID: 10201584)
21. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Lai WW; Fan DS; Chan WM
Eye (Lond); 2005 Aug; 19(8):885-90. PubMed ID: 15389275
[TBL] [Abstract][Full Text] [Related]
22. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy.
Chae JB; Joe SG; Yang SJ; Lee JY; Sung KR; Kim JY; Kim JG; Yoon YH
Retina; 2014 Jan; 34(1):149-56. PubMed ID: 23807186
[TBL] [Abstract][Full Text] [Related]
23. Macular morphology after cataract surgery with primary posterior capsulorhexis and posterior optic buttonholing.
Stifter E; Menapace R; Neumayer T; Luksch A
Am J Ophthalmol; 2008 Jul; 146(1):15-22. PubMed ID: 18439560
[TBL] [Abstract][Full Text] [Related]
24. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.
Browning DJ; Fraser CM; Clark S
Ophthalmology; 2008 Mar; 115(3):533-539.e2. PubMed ID: 18067962
[TBL] [Abstract][Full Text] [Related]
25. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.
Gupta A; Gupta V; Thapar S; Bhansali A
Am J Ophthalmol; 2004 Apr; 137(4):675-82. PubMed ID: 15059707
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
[TBL] [Abstract][Full Text] [Related]
27. [Diabetic retinopathy following cataract surgery].
Parness R; Kleinman G; Katz H; Hauser D; Bukelman A; Leiba H; Knobler H; Schechtman E; Pollack A
Harefuah; 2005 Nov; 144(11):763-7, 824, 823. PubMed ID: 16358648
[TBL] [Abstract][Full Text] [Related]
28. [Surgery of idiopathic epimacular membranes. Prognostic factors].
Gaudric A; Cohen D
J Fr Ophtalmol; 1992; 15(12):657-68. PubMed ID: 1299677
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Audren F; Lecleire-Collet A; Erginay A; Haouchine B; Benosman R; Bergmann JF; Gaudric A; Massin P
Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
31. [Macular edema after cataract surgery in diabetic patients without retinopathy].
Jurecka T; Bátková Z; Ventruba J; Synek S
Cesk Slov Oftalmol; 2007 Jul; 63(4):274-84. PubMed ID: 17682607
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
33. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus.
Hikichi T; Fujio N; Akiba J; Azuma Y; Takahashi M; Yoshida A
Ophthalmology; 1997 Mar; 104(3):473-8. PubMed ID: 9082275
[TBL] [Abstract][Full Text] [Related]
34. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F
Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
[TBL] [Abstract][Full Text] [Related]
35. Foveal cone function in nonproliferative diabetic retinopathy and macular edema.
Weiner A; Christopoulos VA; Gussler CH; Adams DH; Kaufman SR; Kohn HD; Weidenthal DT
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1443-9. PubMed ID: 9191608
[TBL] [Abstract][Full Text] [Related]
36. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
[TBL] [Abstract][Full Text] [Related]
37. Diabetic retinopathy progression and visual outcome after phacoemulsification in South-Asian and Afro-Caribbean patients with diabetes.
Chatterjee S; Savant VV; Stavrou P
Eye (Lond); 2004 Jun; 18(6):575-9. PubMed ID: 14716320
[TBL] [Abstract][Full Text] [Related]
38. [Macular image changes of optical coherence tomography after phacoemulsification].
Cheng B; Liu Y; Liu X; Ge J; Ling Y; Zheng X
Zhonghua Yan Ke Za Zhi; 2002 May; 38(5):265-7. PubMed ID: 12133369
[TBL] [Abstract][Full Text] [Related]
39. Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME).
Akduman L; Olk RJ
Ophthalmic Surg Lasers; 1999; 30(9):706-14. PubMed ID: 10574491
[TBL] [Abstract][Full Text] [Related]
40. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
